Paper68274
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
Reid JL and 5 others. Lancet, 1977. Cited by 151 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Papers, record 68274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68274
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Pressure | Major topic |
| Clonidine | Major topic |
| Hypertension | Major topic |
| Norepinephrine | Major topic |
| Substance Withdrawal Syndrome | Major topic |
| Adult | |
| Female | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,334,325 | Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series. | Drug Alcohol Depend | 2025 | https://conductscience.org/library/papers/40334325 | PubMed |
| 37,955,319 | False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade. | Endocr Relat Cancer | 2024 | https://conductscience.org/library/papers/37955319 | PubMed |
| 10,984,201 | I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly. | Drugs Aging | 2000 | https://conductscience.org/library/papers/10984201 | PubMed |
| 10,595,861 | Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection. | Drugs | 1999 | https://conductscience.org/library/papers/10595861 | PubMed |
| 8,841,737 | The implications of noncompliance with antihypertensive medication. | Drugs | 1996 | https://conductscience.org/library/papers/8841737 | PubMed |
| 8,827,948 | Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine. | Cardiovasc Drugs Ther | 1996 | https://conductscience.org/library/papers/8827948 | PubMed |
| 8,726,097 | Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses. | Clin Auton Res | 1996 | https://conductscience.org/library/papers/8726097 | PubMed |
| 7,510,854 | Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro. | Naunyn Schmiedebergs Arch Pharmacol | 1993 | https://conductscience.org/library/papers/7510854 | PubMed |
| 7,461,012 | Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7461012 | PubMed |
| 7,295,459 | The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7295459 | PubMed |
| 7,230,203 | Drugs causing intestinal obstruction: a review. | J R Soc Med | 1980 | https://conductscience.org/library/papers/7230203 | PubMed |
| 7,195,292 | Clonidine dependence in the guinea-pig isolated ileum. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/7195292 | PubMed |
| 7,050,735 | Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat. | Naunyn Schmiedebergs Arch Pharmacol | 1982 | https://conductscience.org/library/papers/7050735 | PubMed |
| 7,016,550 | Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7016550 | PubMed |
| 7,011,348 | Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7011348 | PubMed |
| 7,007,060 | Long-term clonidine effects on autonomic function in essential hypertensive man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7007060 | PubMed |
| 7,007,059 | Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7007059 | PubMed |
| 6,994,774 | Guanfacine: effects of long-term treatment and withdrawal. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6994774 | PubMed |
| 6,994,770 | Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6994770 | PubMed |
| 6,992,462 | Antihypertensive pharmacology. | West J Med | 1980 | https://conductscience.org/library/papers/6992462 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68274
GET https://conductscience.org/api/papers/v1/68274/cited_by?page=2